Featured Research

from universities, journals, and other organizations

Molecular Fingerprint Predicts HIV-associated Dementia

Date:
June 25, 2003
Source:
NIH/National Institute Of Neurological Disorders And Stroke
Summary:
A new study using a cutting edge research technique called "proteomics protein fingerprinting" shows that HIV patients with dementia have distinct protein patterns in their blood, setting them apart from patients with no symptoms of dementia.

A new study using a cutting edge research technique called "proteomics protein fingerprinting" shows that HIV patients with dementia have distinct protein patterns in their blood, setting them apart from patients with no symptoms of dementia. The study suggests a possible way to screen HIV patients for the first signs of cognitive impairment.

"Characterizing dementia in this way is a very new and exciting approach," says study author Loyda Melendez, Ph.D., of the University of Puerto Rico Medical Sciences Campus in San Juan. "It's a ways off, but our research tells us that we might eventually be able to use a blood test to look for signs of HIV-associated dementia (HAD)." Dr. Melendez' group collaborated with researchers led by Howard E. Gendelman, M.D., of the University of Nebraska Medical Center in Omaha. The study was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) and appears in the June 24, 2003, issue of Neurology.*

About 10 to 15 percent of people living with HIV eventually develop HAD. The condition causes loss of memory and thinking abilities. Patients also may have motor deterioration and/or changes in their behavior and personality.

Researchers do not know how HIV infection leads to HAD. In this study, the researchers tested a unique hypothesis that HIV attacks immune cells in the blood that travel to the brain, rather than infecting the nerve cells. In a healthy individual, those blood immune cells, called monocytes, nourish the brain. However, studies have suggested that in a person with HAD, the corrupted immune cells may release substances that damage brain cells.

Dr. Valerie Wojna, M.D., and Dr. Melendez developed a cohort of Hispanic women at the University of Puerto Rico Medical Sciences Campus. Within 3 months complete neurological testing was done and blood samples were obtained from 31 Puerto Rican women aged 21-45 years. Nine of the women had HIV with relatively high levels of cognitive impairment, 12 had HIV without dementia, and 10 control subjects were HIV-negative and had no cognitive impairment.

Researchers at Nebraska then used a relatively new technique known as proteomics, which maps out patterns of activity for particular groups of proteins, essentially providing a molecular "fingerprint" unique to each patient.

Proteomic analysis showed that of the 177 proteins examined in the study, 38 proteins exhibited different activity levels in the HAD groups than in people without dementia. All of the patients with the distinct protein pattern were HAD-positive, but not all HAD patients had the profile.

The findings suggest that physicians may one day be able to screen for HAD using a simple blood test. A blood test would be quicker, less expensive, and more specific than currently used magnetic resonance imaging techniques and clinical evaluations. Even further down the road, researchers might be able to identify specific proteins responsible for causing the dementia. If researchers can find ways to inhibit those proteins, they might be able to prevent the onset of dementia.

Studies need to be done to more fully describe the protein profile for HAD, says Dr. Gendelman. "Our results are encouraging, but proteomics is still in its infancy. We've taken the first step in a very long journey to find better ways to diagnose HAD and other diseases."

The researchers have followed the same group of patients and healthy subjects for one year, and they plan to continue following them for another year, Dr. Melendez says. They also hope to double the number of study subjects in the future, in order to improve the statistical significance of their results, and to begin including men in the studies.

In addition to continuing the current work, the researchers plan to purify and sequence the proteins that are altered in HAD and to see how the protein patterns change over time as patients improve or decline. They also hope to examine whether genetic factors influence HIV dementia.

The study represents some of the first published results from one of the National Institutes of Health (NIH)'s Specialized Neuroscience Research Programs (SNRPs). The SNRP awards are designed to help minority institutions develop state-of-the-art neuroscience research programs, prepare the next generation of neuroscience investigators, and create opportunities for collaborations among researchers at minority institutions and other NIH grantees. Directing the SNRP program and coordinating the research between the Medical Sciences Campus and the University of Nebraska is Edmundo Kraiselburd, Ph.D., professor and director of the Unit of Comparative Medicine.

"The publication of such important results from this team of investigators in HIV-1/AIDS indicates that the NINDS-designed SNRP program, matching promising investigators from minority institutions with experienced scientists from larger medical centers, was well designed and is hitting its benchmarks for success," commented Eugene Major, Ph.D., an AIDS investigator and Acting Deputy Director of the NINDS.

The NINDS is a component of the National Institutes of Health within the Department of Health and Human Services and is the nation's primary supporter of biomedical research on the brain and nervous system.

*Luo X, Carlson KA, Wojna V, Mayo R, Biskup T, Stoner J, Anderson J, Gendelman HE, Melendez LM. "Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment." Neurology, June 24, 2003, Vol. 60, pp. 1931-1937.


Story Source:

The above story is based on materials provided by NIH/National Institute Of Neurological Disorders And Stroke. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute Of Neurological Disorders And Stroke. "Molecular Fingerprint Predicts HIV-associated Dementia." ScienceDaily. ScienceDaily, 25 June 2003. <www.sciencedaily.com/releases/2003/06/030624085952.htm>.
NIH/National Institute Of Neurological Disorders And Stroke. (2003, June 25). Molecular Fingerprint Predicts HIV-associated Dementia. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2003/06/030624085952.htm
NIH/National Institute Of Neurological Disorders And Stroke. "Molecular Fingerprint Predicts HIV-associated Dementia." ScienceDaily. www.sciencedaily.com/releases/2003/06/030624085952.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins